SDS

Page 7 of 10
Information on Toxicological Effects
Symptoms
May cause redness and tearing of the eyes, coughing and/or wheezing, itching, rashes and hives.
Delayed and Immediate Effects as well as Chronic Effects from Short and Long-Term Exposure
Sensitization
May cause sensitization of susceptible persons. May cause sensitization by skin contact.
Mutagenic Effects
No information available
Carcinogenicity
No carcinogens present
ACGIH (American Conference of Governmental Industrial Hygienists)
A2 – Suspected Human Carcinogen
IARC (International Agency for Research on Cancer)
Group 2B – Possibly Carcinogenic to Humans
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X-Present
Reproductive Toxicity, STOT Single Exposure, STOT Repeated Exposure:
No information available
Chronic Toxicity
Titanium dioxide has been classified by the International Agency for Research on Cancer (IARC) as
possibly carcinogenic to humans (Group 2B) by inhalation. Contains a known or suspected carcinogen.
Target Organ Effects
Eyes, respiratory system, skin, gastrointestinal tract (GI) & lungs.
Aspiration Hazard
No information available
Numerical Measures of Toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral) ATEmix (inhalation-dust/mist)
8,711.00 mg/kg 2.41 mg/l
ATEmix (dermal) ATEmix (inhalation-vapor)
21,608.00 mg/kg (ATE) 16.00 ATEmix
ATEmix (inhalation-gas)
3,118.00 ppm (4hr)